HeartRhythm

OCTOBER 19, 2023

Hypertrophic cardiomyopathy (HCM)-related sudden cardiac death (SCD) rates with contemporary management are low; however, high-intensity exercise can induce fatal arrhythmias in HCM patients. Thus, current guidelines recommend avoiding high-intensity exercise in HCM patients at high risk for SCD1,2.

Exercise 40

Exercise Cardiomyopathy Sudden Cardiac Death Cardiovascular Disease 40

Physiologically Speaking

FEBRUARY 28, 2024

These numbers indicate rising participation — an increase in people involved in chronic endurance exercise training for the sake of competition and health. A list of the causes of death reveals an underlying pattern. Many, but not all, are cardiac-related issues (i.e., ” Isn’t exercise good for us? .”

Exercise 98

Exercise Sudden Cardiac Death Physiology Congenital 98

DAIC

APRIL 9, 2024

Maron, MD “Our findings provide enthusiasm that a novel drug therapy with ninerafaxstat may provide nonobstructive HCM patients an opportunity to achieve a better quality of life by decreasing symptom burden and improving exercise capacity,” said Martin S. For more information on hypertrophic cardiomyopathy, visit CardioSmart.org/HCM.

Cardiomyopathy 52

Cardiomyopathy Quality of Life Preserved Ejection Fraction Chest Pain 52

DAIC

MAY 9, 2024

The American College of Cardiology (ACC) and the American Heart Association (AHA) today released a new clinical guideline for effectively managing individuals diagnosed with hypertrophic cardiomyopathy (HCM). Ommen, MD, FACC , medical director of the Mayo Hypertrophic Cardiomyopathy Clinic and chair of the guideline writing committee.

Cardiomyopathy 52

Cardiomyopathy Pediatrics Quality of Life Sudden Cardiac Death 52

DAIC

OCTOBER 2, 2024

Director of the Hypertrophic Cardiomyopathy Center at the Lahey Hospital and Medical Center. These data elaborate on the primary results from SEQUOIA-HCM and further inform the relevance to clinical practice of aficamten as a next-in-class cardiac myosin inhibitor for adult patients with obstructive HCM.” References: Maron M, et al.

Cardiomyopathy 52

Cardiomyopathy Sudden Cardiac Death Biomarkers Heart Failure 52

European Journal of Heart Failure

NOVEMBER 14, 2023

Sudden cardiac death in cardiomyoptahies: incidence, risk factors and prevention. Significant LGE at CMR; LVEF <50%; abnormal blood pressure response during exercise test; LV apical aneurysm; high-risk genotype. However, unresolved issues still challenge the guidance of SCD prevention in patients with cardiomyopathies.

Sudden Cardiac Death 40

Sudden Cardiac Death Cardiomyopathy Risk Factors Heart Failure 40

Circulation

DECEMBER 17, 2023

BACKGROUND:Exercise-induced cardiac remodeling can be profound, resulting in clinical overlap with dilated cardiomyopathy, yet the significance of reduced ejection fraction (EF) in athletes is unclear. Circulation, Ahead of Print. During follow-up, no athletes developed symptomatic heart failure or arrhythmias.

Genetic predisposition 77

Genetic predisposition Cardiomyopathy Sudden Cardiac Death Heart Failure 77